Nigerian drug makers are pushing on with investments and expansion but key challenges remain unresolved in the industry. Even the acquisition of the World Health Organisation (WHO)’s prequalification has not helped some of them as expected, as exchange rate exposure and policy issues dog the industry. Swiss Pharma, which was the first to get the…